King Pharmaceuticals

North America

Canada (0)
No result.
United States (65)
X
Product
Pack
Market
Pres.
Dosage
ATC
API
ALTACE tabs
N
N
N
N



oral
C09AA05
ALTACE 1.25MG caps
Y
Rx
oral
C09AA05
ALTACE 10MG caps
Y
Rx
oral
C09AA05
ALTACE 2.5MG caps
Y
Rx
oral
C09AA05
ALTACE 5MG caps
Y
Rx
oral
C09AA05
AMINOPHYLLINE 25MG/ML inj
N
INJECTION
R03DA05
APOGEN EQ 10MG BASE/ML inj
N
INJECTION
J01GB03
APOGEN EQ 40MG BASE/ML inj
N
INJECTION
J01GB03
AVINZA 120MG xr caps
N
oral
N02AA01
AVINZA 30MG xr caps
N
oral
N02AA01
AVINZA 45MG xr caps
N
oral
N02AA01
AVINZA 60MG xr caps
N
oral
N02AA01
AVINZA 75MG xr caps
N
oral
N02AA01
AVINZA 90MG xr caps
N
oral
N02AA01
BICILLIN C-R 150,000 UNITS/ML;150,000 UNITS/ML inj
N
INJECTION
0
BICILLIN C-R 300,000 UNITS/ML;300,000 UNITS/ML inj
Y
Rx
INJECTION
0
BICILLIN C-R 900/300 900,000 UNITS/2ML;300,000 UNITS/2ML inj
Y
Rx
INJECTION
0
BICILLIN L-A 300,000 UNITS/ML inj
N
INJECTION
0
BICILLIN L-A 600,000 UNITS/ML inj
Y
Rx
INJECTION
0
CORZIDE 5MG;40MG tabs
Y
Rx
oral
C07BA12
CORZIDE 5MG;80MG tabs
Y
Rx
oral
C07BA12
CROMOPTIC 4% SOLUTION/DROPS
N
ocular
S01GX01
CYTOMEL EQ 0.005MG BASE tabs
Y
Rx
oral
H03AA02
CYTOMEL EQ 0.025MG BASE tabs
Y
Rx
oral
H03AA02
CYTOMEL EQ 0.05MG BASE tabs
Y
Rx
oral
H03AA02
HUMATIN EQ 250MG BASE caps
N
oral
A07AA06
INTAL sol
N
inh
R03BC01
INTAL 0.8MG/INH md aerosol
N
inh
R03BC01
KLEBCIL EQ 1GM BASE/3ML inj
N
INJECTION
J01GB04
KLEBCIL EQ 500MG BASE/2ML inj
N
INJECTION
J01GB04
KLEBCIL EQ 75MG BASE/2ML inj
N
INJECTION
J01GB04
LEVOXYL tabs
N
oral
H03AA01
LEVOXYL 0.025MG **SEE CURRENT ANNUAL EDITION, 1.8 DESCRIPTIO tabs
Y
Rx
oral
H03AA01
LEVOXYL 0.05MG **SEE CURRENT ANNUAL EDITION, 1.8 DESCRIPTION tabs
Y
Rx
oral
H03AA01
LEVOXYL 0.075MG **SEE CURRENT ANNUAL EDITION, 1.8 DESCRIPTIO tabs
Y
Rx
oral
H03AA01
LEVOXYL 0.088MG **SEE CURRENT ANNUAL EDITION, 1.8 DESCRIPTIO tabs
Y
Rx
oral
H03AA01
LEVOXYL 0.112MG **SEE CURRENT ANNUAL EDITION, 1.8 DESCRIPTIO tabs
Y
Rx
oral
H03AA01
LEVOXYL 0.125MG **SEE CURRENT ANNUAL EDITION, 1.8 DESCRIPTIO tabs
Y
Rx
oral
H03AA01
LEVOXYL 0.137MG **SEE CURRENT ANNUAL EDITION, 1.8 DESCRIPTIO tabs
Y
Rx
oral
H03AA01
LEVOXYL 0.15MG **SEE CURRENT ANNUAL EDITION, 1.8 DESCRIPTION tabs
Y
Rx
oral
H03AA01
LEVOXYL 0.175MG **SEE CURRENT ANNUAL EDITION, 1.8 DESCRIPTIO tabs
Y
Rx
oral
H03AA01
LEVOXYL 0.1MG **SEE CURRENT ANNUAL EDITION, 1.8 DESCRIPTION tabs
Y
Rx
oral
H03AA01
LEVOXYL 0.2MG **SEE CURRENT ANNUAL EDITION, 1.8 DESCRIPTION tabs
Y
Rx
oral
H03AA01
LORABID 100MG/5ML FOR SUSPENSION
N
oral
J01DC08
LORABID 200MG caps
N
oral
J01DC08
LORABID 200MG/5ML FOR SUSPENSION
N
oral
J01DC08
LORABID 400MG caps
N
oral
J01DC08
MAXOLON EQ 10MG BASE tabs
N
oral
A03FA01
PENICILLIN G PROCAINE 300,000 UNITS/ML inj
Y
Rx
INJECTION
0
PENICILLIN G PROCAINE 600,000 UNITS/ML inj
Y
Rx
INJECTION
0
PROCANBID 1GM xr tabs
N
oral
C01BA02
PROCANBID 500MG xr tabs
N
oral
C01BA02
QUINIDINE SULFATE 200MG tabs
N
oral
C01BA01
SILVADENE 1% cream
Y
Rx
topical
D06BA01
SKELAXIN tabs
N
oral
X000075
SKELAXIN 800MG tabs
Y
Rx
oral
X000075
SYNERCID 350MG/VIAL;150MG/VIAL inj
Y
Rx
iv
J01FG02
SYNERCID 420MG/VIAL;180MG/VIAL inj
N
iv
J01FG02
SYNERCID 500MG inj
Y
Rx
INJECTION
J01FG02
TAPAZOLE tabs
N
N

oral
H03BB02
TAPAZOLE 10MG tabs
Y
Rx
oral
H03BB02
TAPAZOLE 5MG tabs
Y
Rx
oral
H03BB02
TIGAN 300MG caps
Y
Rx
oral
R06AA10
TILADE 1.75MG/INH md aerosol
N
inh
R03BC03
TUSSIGON 1.5MG;5MG tabs
N
oral
0
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
ALTACE tabs
22021/4
22021/3
22021/2
22021/1
NDA
NDA
NDA
NDA
27-02-2007
27-02-2007
27-02-2007
27-02-2007
ALTACE 1.25MG caps
19901/1
NDA
28-01-1991
ALTACE 10MG caps
19901/4
NDA
28-01-1991
ALTACE 2.5MG caps
19901/2
NDA
28-01-1991
ALTACE 5MG caps
19901/3
NDA
28-01-1991
AMINOPHYLLINE 25MG/ML inj
86606/1
ANDA
01-01-1982
APOGEN EQ 10MG BASE/ML inj
62289/1
ANDA
01-01-1982
APOGEN EQ 40MG BASE/ML inj
62289/2
ANDA
01-01-1982
AVINZA 120MG xr caps
21260/4
NDA
20-03-2002
AVINZA 30MG xr caps
21260/1
NDA
20-03-2002
AVINZA 45MG xr caps
21260/5
NDA
18-12-2008
AVINZA 60MG xr caps
21260/2
NDA
20-03-2002
AVINZA 75MG xr caps
21260/6
NDA
18-12-2008
AVINZA 90MG xr caps
21260/3
NDA
20-03-2002
BICILLIN C-R 150,000 UNITS/ML;150,000 UNITS/ML inj
50138/2
NDA
01-01-1982
BICILLIN C-R 300,000 UNITS/ML;300,000 UNITS/ML inj
50138/1
NDA
01-01-1982
BICILLIN C-R 900/300 900,000 UNITS/2ML;300,000 UNITS/2ML inj
50138/3
NDA
01-01-1982
BICILLIN L-A 300,000 UNITS/ML inj
50141/3
NDA
01-01-1982
BICILLIN L-A 600,000 UNITS/ML inj
50141/1
NDA
01-01-1982
CORZIDE 5MG;40MG tabs
18647/1
NDA
25-05-1983
CORZIDE 5MG;80MG tabs
18647/2
NDA
25-05-1983
CROMOPTIC 4% SOLUTION/DROPS
75088/1
ANDA
27-04-1999
CYTOMEL EQ 0.005MG BASE tabs
10379/1
NDA
01-01-1982
CYTOMEL EQ 0.025MG BASE tabs
10379/2
NDA
01-01-1982
CYTOMEL EQ 0.05MG BASE tabs
10379/3
NDA
01-01-1982
HUMATIN EQ 250MG BASE caps
62310/1
ANDA
01-01-1982
INTAL sol
18596/1
NDA
28-05-1982
INTAL 0.8MG/INH md aerosol
18887/1
NDA
05-12-1985
KLEBCIL EQ 1GM BASE/3ML inj
62170/3
ANDA
01-01-1982
KLEBCIL EQ 500MG BASE/2ML inj
62170/2
ANDA
01-01-1982
KLEBCIL EQ 75MG BASE/2ML inj
62170/1
ANDA
01-01-1982
LEVOXYL tabs
21301/12
NDA
25-05-2001
LEVOXYL 0.025MG **SEE CURRENT ANNUAL EDITION, 1.8 DESCRIPTIO tabs
21301/1
NDA
25-05-2001
LEVOXYL 0.05MG **SEE CURRENT ANNUAL EDITION, 1.8 DESCRIPTION tabs
21301/2
NDA
25-05-2001
LEVOXYL 0.075MG **SEE CURRENT ANNUAL EDITION, 1.8 DESCRIPTIO tabs
21301/3
NDA
25-05-2001
LEVOXYL 0.088MG **SEE CURRENT ANNUAL EDITION, 1.8 DESCRIPTIO tabs
21301/4
NDA
25-05-2001
LEVOXYL 0.112MG **SEE CURRENT ANNUAL EDITION, 1.8 DESCRIPTIO tabs
21301/6
NDA
25-05-2001
LEVOXYL 0.125MG **SEE CURRENT ANNUAL EDITION, 1.8 DESCRIPTIO tabs
21301/7
NDA
25-05-2001
LEVOXYL 0.137MG **SEE CURRENT ANNUAL EDITION, 1.8 DESCRIPTIO tabs
21301/8
NDA
25-05-2001
LEVOXYL 0.15MG **SEE CURRENT ANNUAL EDITION, 1.8 DESCRIPTION tabs
21301/9
NDA
25-05-2001
LEVOXYL 0.175MG **SEE CURRENT ANNUAL EDITION, 1.8 DESCRIPTIO tabs
21301/10
NDA
25-05-2001
LEVOXYL 0.1MG **SEE CURRENT ANNUAL EDITION, 1.8 DESCRIPTION tabs
21301/5
NDA
25-05-2001
LEVOXYL 0.2MG **SEE CURRENT ANNUAL EDITION, 1.8 DESCRIPTION tabs
21301/11
NDA
25-05-2001
LORABID 100MG/5ML FOR SUSPENSION
50667/1
NDA
31-12-1991
LORABID 200MG caps
50668/1
NDA
31-12-1991
LORABID 200MG/5ML FOR SUSPENSION
50667/2
NDA
31-12-1991
LORABID 400MG caps
50668/2
NDA
05-04-1996
MAXOLON EQ 10MG BASE tabs
70106/1
ANDA
04-03-1986
PENICILLIN G PROCAINE 300,000 UNITS/ML inj
60101/2
ANDA
01-01-1982
PENICILLIN G PROCAINE 600,000 UNITS/ML inj
60101/1
ANDA
01-01-1982
PROCANBID 1GM xr tabs
20545/2
NDA
31-01-1996
PROCANBID 500MG xr tabs
20545/1
NDA
31-01-1996
QUINIDINE SULFATE 200MG tabs
85175/1
ANDA
01-01-1982
SILVADENE 1% cream
17381/1
NDA
01-01-1982
SKELAXIN tabs
13217/1
NDA
01-01-1982
SKELAXIN 800MG tabs
13217/3
NDA
30-08-2002
SYNERCID 350MG/VIAL;150MG/VIAL inj
50748/1
NDA
21-09-1999
SYNERCID 420MG/VIAL;180MG/VIAL inj
50748/2
NDA
24-08-2000
SYNERCID 500MG inj
50747/1
NDA
TAPAZOLE tabs
7517/4
7517/2
NDA
NDA
01-01-1982
01-01-1982
TAPAZOLE 10MG tabs
40320/2
ANDA
31-03-2000
TAPAZOLE 5MG tabs
40320/1
ANDA
31-03-2000
TIGAN 300MG caps
17531/6
NDA
13-12-2001
TILADE 1.75MG/INH md aerosol
19660/1
NDA
30-12-1992
TUSSIGON 1.5MG;5MG tabs
88508/1
ANDA
30-07-1985
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Europe

Austria (0)
No result.
Belgium (0)
No result.
Bosnia and Herzegovina (0)
No result.
Croatia (0)
No result.
Czechia (0)
No result.
Denmark (0)
No result.
Finland (0)
No result.
Hungary (0)
No result.
Iceland (0)
No result.
Ireland (0)
No result.
Lithuania (0)
No result.
Malta (0)
No result.
Netherlands (0)
No result.
Norway (2)
X
Product
Pack
Market
Pres.
Dosage
ATC
API
CAPREOMYCIN PULV TIL 1 G powd for inj
1
-
Rx
Intramuskulær bruk, Ikke angitt
J04AB30
CYCLOSERINE 250 MG caps
100
-
Rx
oral
J04AB01
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
CAPREOMYCIN PULV TIL 1 G powd for inj
1
15-06-2015
CYCLOSERINE 250 MG caps
100
01-01-2001
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Poland (0)
No result.
Romania (0)
No result.
Slovenia (0)
No result.
Spain (0)
No result.
Sweden (0)
No result.
Switzerland (0)
No result.